Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats

References

• Alatsakis, M., et al., 2009. Early propranolol administration does not prevent development of esophageal varices in cirrhotic rats. European Surgical Research, 42 (1), 11–16.
   PubMed Web of Science ®Google Scholar
• Bañares, R., et al., 1999. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology, 30 (1), 79–83.
   PubMed Web of Science ®Google Scholar
• Bataller, R., and Brenner, D.A., 2005. Liver fibrosis. The Journal of Clinical Investigation, 115 (2), 209–218.
   PubMed Web of Science ®Google Scholar
• Bedossa, P., and Poynard, T., 1996. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group Hepatology, 24, 289–293.
   Google Scholar
• Buege, J.A., and Aust, S.D., 1978. Microsomal lipid peroxidation. Methods in Enzymology, 52, 302–310.
   PubMedGoogle Scholar
• Cao, B.-Q., et al., 2007. Contribution of mononuclear bone marrow cells to carbon tetrachloride-induced liver fibrosis in rats. World Journal of Gastroenterology, 13 (12), 1851–1856.
   PubMed Web of Science ®Google Scholar
• Cheung, P.-Y., et al., 2006. Effect of WeiJia on carbon tetrachloride induced chronic liver injury. World Journal of Gastroenterology, 28 (12), 1912–1917.
   Google Scholar
• Dubuisson, L., et al., 2002. Inhibition of rat liver fibrogenesis through noradrenergic antagonism. Hepatology (Baltimore, Md.), 35 (2), 325–331.
   PubMed Web of Science ®Google Scholar
• Esler, M., et al., 1992. Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Annals of Internal Medicine, 116 (6), 446–455.
   PubMed Web of Science ®Google Scholar
• Fiorucci, S., et al., 2001. NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension. Proceedings of the National Academy of Sciences of the United States of America, 98 (15), 8897–8902.
   PubMed Web of Science ®Google Scholar
• Flohé, L., and Günzler, W.A., 1984. Assays of glutathione peroxidase. Methods in Enzymology, 105, 114–121.
   PubMed Web of Science ®Google Scholar
• Fortune, B.E., et al., 2009. Vapreotide: a somatostatin analog for the treatment of acute variceal bleeding. Expert Opinion on Pharmacotherapy, 10 (14), 2337–2342.
   PubMed Web of Science ®Google Scholar
• Frautschy, S.A., et al., 2001. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiology of Aging, 22 (6), 993–1005.
   PubMed Web of Science ®Google Scholar
• Greenwel, P., et al., 2000. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology, 31 (1), 109–116.
   PubMed Web of Science ®Google Scholar
• Groszmann, R.J., et al., 2005. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. New England Journal of Medicine, 353 (21), 2254–2261.
   PubMed Web of Science ®Google Scholar
• Hamilton, R.L., et al., 1974. A simple and inexpensive membrane "lung" for small organ perfusion. Journal of Lipid Research, 15 (2), 182–186.
   PubMed Web of Science ®Google Scholar
• Hoebe, K.H., et al., 2004. Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflammation Research, 53 (3), 93–99.
   PubMed Web of Science ®Google Scholar
• Lin, H.C., et al., 2004. Acute administration of carvedilol is more effective than propranolol plus isosorbide-5-mononitrate in the reduction of portal pressure in patients with viral cirrhosis. The American Journal of Gastroenterology, 99 (10), 1953–1958.
   PubMedGoogle Scholar
• Lysko, P.G., et al., 1998. Neuroprotective activitiesof carvedilol and a hydroxylated derivative, role of membrane biophysical interactions. Biochemical pharmacology, 56 (12), 1645–1656.
   PubMed Web of Science ®Google Scholar
• Marra, F., 1999. Hepatic stellate cells and the regulation of liver inflammation. Journal of Hepatology, 31 (6), 1120–1130.
   PubMed Web of Science ®Google Scholar
• Marteau, P., et al., 1989. Effect of vasodilators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology, 9 (6), 820-823.
   Google Scholar
• Matei, V., et al., 2006. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis. Hepatology (Baltimore, Md.), 44 (1), 44–52.
   PubMed Web of Science ®Google Scholar
• Matsumoto, H., et al., 2000. Role of kuppfer cells in the release of nitric oxide and change of portal pressure after ethanol perfusion in the rat liver. Alcohol and Alcoholism, 35 (1), 31–34.
   PubMed Web of Science ®Google Scholar
• Merrick, B.A., et al., 2006. Alterations in the rat serum proteome during liver injury from acetaminophen exposure. The Journal of Pharmacology and Experimental Therapeutics, 318 (2), 792–802.
   PubMed Web of Science ®Google Scholar
• Moal, F., et al., 2006. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World Journal of Gastroenterology, 7 (41), 6639. 6645
   Google Scholar
• Morishita, K., et al., 2006. Gene expression profile in liver of differing ages of rats after single oral administration of acetaminophen. The Journal of Toxicological Sciences, 31 (5), 491–507.
   PubMedGoogle Scholar
• Oben, J.A., and Diehl, A.M., 2004. Sympathetic nervous system regulation of liver repair. The Anatomical Record. Part A, Discoveries in Molecular, Cellular, and Evolutionary Biology, 280 (1), 874–883.
   PubMedGoogle Scholar
• Oben, J.A., et al., 2003. Norepinephrine and neuropeptide Y promote proliferation and collagen gene expression of hepatic myofibroblastic stellate cells. Biochemical and Biophysical Research Communications, 302 (4), 685–690.
   PubMed Web of Science ®Google Scholar
• Pérez Tamayo, R., 1983. Is cirrhosis of the liver experimentally produced by CCl4 and adequate model of human cirrhosis? Hepatology, 3, 112–120.
   PubMed Web of Science ®Google Scholar
• Rahman, T.M., and Hodgson, H.J., 2000. Animal models of acute hepatic failure. International Journal of Experimental Pathology, 81 (2), 145–157.
   PubMed Web of Science ®Google Scholar
• Ramos, B.P., et al., 2005. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biological Psychiatry, 58 (11), 894–900.
   PubMed Web of Science ®Google Scholar
• Randle, L.E., et al., 2008. A1-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice. British Journal of Pharmacology, 153 (4), 820–830.
   PubMed Web of Science ®Google Scholar
• Reynaert, H., et al., 2002. Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut, 50 (4), 571–581.
   PubMed Web of Science ®Google Scholar
• Rössig, L., et al., 2000. Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. Journal of the American College of Cardiology, 36 (7), 2081–2089.
   PubMed Web of Science ®Google Scholar
• Sancho-Bru, P., et al., 2006. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells. American Journal of Physiology. Gastrointestinal and Liver Physiology, 291 (5), G877–G884.
   PubMed Web of Science ®Google Scholar
• Singh, A., et al., 2002. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. Journal of Medicinal Food, 5 (4), 211–220.
   PubMedGoogle Scholar
• Trim, N., et al., 2000. Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. The American Journal of Pathology, 156 (4), 1235–1243.
   PubMed Web of Science ®Google Scholar
• Tripathi, D., and Hayes, P.C., 2010. The role of carvedilol in the management of portal hypertension. European Journal of Gastroenterology and Hepatology, 22 (8), 905–911.
   PubMed Web of Science ®Google Scholar
• Tsochatzis, E.A., Triantos, C.K., and Burroughs, A.K., 2009. Gastrointestinal bleeding: carvedilol-the best beta-blocker for primary prophylaxis? Nature Reviews. Gastroenterology and Hepatology, 6 (12), 692–694.
   PubMed Web of Science ®Google Scholar
• Vom Dahl, S., et al., 1999. Release of osmolytes from perfused rat liver on perivascular nerve stimulation: alpha-adrenergic control of osmolyte efflux from parenchymal and nonparenchymal liver cells. Hepatology (Baltimore, Md.), 29 (1), 195–204.
   PubMed Web of Science ®Google Scholar
• Walldorf, J., et al., 2010. Propranolol impairs liver regeneration after partial hepatectomy in C57Bl/6-mice by transient attenuation of hepatic lipid accumulation and increased apoptosis. Scandinavian Journal of Gastroenterology, 45 (4), 468–476.
   PubMed Web of Science ®Google Scholar
• Wang, R., et al., 2006. Pleiotropic effects of the B adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes. The Journal of Pharmacology and Experimental Therapeutics, 318 (1), 45–52.
   PubMed Web of Science ®Google Scholar
• Yue, T.L., et al., 1995. Carvedilol, a new vasodilating beta-adrenoceptor blocker, inhibits oxidation of low-density lipoproteins by vascular smooth muscle cells and prevents leukocyte adhesion to smooth muscle cells. The Journal of Pharmacology and Experimental Therapeutics, 273 (3), 1442–1449.
   PubMed Web of Science ®Google Scholar
• Yue, T.L., et al., 1998. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circulation Research, 82 (2), 166–174.
   PubMed Web of Science ®Google Scholar